Diabetes Mellitus Clinical Trial
Official title:
Response of Inflammatory Markers to Circuit Weight Training in Diabetic Patients
Study group included 30 male diabetic patients , they performed circuit weight training
exercises for 12 weeks in addition to their medications. However, the control group included
10 patients received medical treatment.
Interleukin 6 and tumor necrosis factor alpha were measured before and after the study
duration for both groups.
The study group included 30 male diabetic patients who participated in circuit weight
training (CWT) program as following; 60 minutes training\day for 3 days per week for a period
of 12 weeks.
The training session started by a proper warm up for 5-10 min in the form of mild stretching
of the muscles of upper limb(pectorals,shoulder girdle muscles) and muscles of lower
limb(flexors, extensors, abductors and adductors of the hip and knee) ( to minimize the risk
of musculoskeletal injury). Then start the active phase of resisted exercises through using
free weights ( dumbbels for upper limb and sand bags for lower limb) The frequency and
intensity increased gradually as follows; Intensity of progress of CWT gradually increased
intensity by 2.5% of one repetition maximum every two weeks. Moderate resistance used in
which of 60-65% of 1RM in the first month then the intensity increased to 70-75% of 1RM in
the second month and finally the intensity of exercises increased to 75-80% of 1RM during the
third month. The sets of exercises intervened by 1 min rest in between each set of
repetitions. At last the session ends by 10 min of cooling down in the form of relaxation
exercises.
Statistical procedures:
In this study, the descriptive statistics (the mean, the standard deviation, maximum,
minimum, and range) will be calculated for all subjects in the study including IL6 and tumor
necrosis factor alpha variables.
- Paired sample t-test will be used to compare the difference between before and after
treatment results of IL6 and tumor necrosis factor alpha in each group.
- Paired T test to compare means of variables before and after training.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
| Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
| Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
| Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
| Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
| Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
| Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
| Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
| Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
| Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
| Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
| Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
| Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
| Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
| Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
| Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |